Reduced Vascular Endothelial Growth Factor and Capillary Density in the Occipital Cortex in Dementia with Lewy Bodies
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
In dementia with L ewy bodies (DLB), blood flow tends to be reduced in the occipital cortex. We previously showed elevated activity of the endothelin and angiotensin pathways in A lzheimer's disease (AD). We have measured endothelin‐1 (ET‐1) level and angiotensin‐converting enzyme (ACE) activity in the occipital cortex in DLB and control brains. We also measured vascular endothelial growth factor (VEGF); factor VIII‐related antigen (FVIIIRA) to indicate microvessel density; myelin‐associated glycoprotein (MAG), a marker of ante‐mortem hypoperfusion; total α‐synuclein (α‐syn) and α‐synuclein phosphorylated at S er129 (α‐syn‐p129). In contrast to findings in AD, ACE activity and ET‐1 level were unchanged in DLB compared with controls. VEGF and FVIIIRA levels were, however, significantly lower in DLB. VEGF correlated positively with MAG concentration (in keeping with a relationship between reduction in VEGF and hypoperfusion), and negatively with α‐syn and α‐syn‐p129 levels. Both α‐syn and α‐syn‐p129 levels increased in human SH‐SY 5 Y neuroblastoma cells after oxygen‐glucose deprivation (OGD), and VEGF level was reduced in SH‐SY 5 Y cells overexpressing α‐syn. Taken together, our findings suggest that reduced microvessel density rather than vasoconstriction is responsible for lower occipital blood flow in DLB, and that the loss of microvessels may result from VEGF deficiency, possible secondary to the accumulation of α‐syn.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · cited 1×
“Controls had no history of dementia and no neuropathological abnormalities apart from mild neurofibrillary tangle pathology (Braak tangle stage III or less) (10) and scattered diffuse Aβ plaques in some cases.”
BackgroundRegulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
VEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9369 · Cited by 1,296 · cited 1×
“mechanism which underlie reduced CBF in DLB and found that (i) the levels of ET-1 and ACE, two potent vasoconstrictors that are upregulated in the cerebral cortex in AD, were unchanged in DLB (ii); VEGF, a potent pro-angiogenic factor (41, 64), is reduced in DLB (iii); FVIIIRA level, a good surrogate marker of capilli…”
BackgroundSondell, M., Lundborg, G., & Kanje, M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05731.1999 · Cited by 750 · cited 1×
“VEGF is a pro-angiogenic (41, 63) neurotrophic factor (49, 51, 52) and is elevated in AD (30, 54).”
BackgroundCerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study
Ruitenberg, A., den Heijer, T., Bakker, S. L. M., van Swieten, J. C., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20493 · Cited by 733
Zhang, X., Zhou, K., Wang, R., Cui, J., Lipton, S. A., Liao, F.-F., Xu, H., & Zhang, Y.-W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608856200 · Cited by 436
Tarkowski, E., Issa, R., Sjögren, M., Wallin, A., Blennow, K., Tarkowski, A., & Kumar, P. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00285-8 · Cited by 360 · cited 1×
“VEGF is a pro-angiogenic (41, 63) neurotrophic factor (49, 51, 52) and is elevated in AD (30, 54).”
BackgroundNiwa, K., Kazama, K., Younkin, S. G., Carlson, G. A., & Iadecola, C. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0460 · Cited by 218 · cited 2×
“Mice overexpressing mutant human Aβ precursor protein (APP) show reduction in CBF well before the development of pathological or neurological abnormalities (39).”
BackgroundAβ-peptides enhance vasoconstriction in cerebral circulation
Niwa, K., Porter, V. A., Kazama, K., Cornfield, D., Carlson, G. A., & Iadecola, C. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.6.h2417 · Cited by 202 · cited 2×
“Aβ peptides also cause cerebral vasoconstriction (25, 40) which we have shown to be at least partly attributable to increased production of the vasoconstrictor ET-1 and of ACE (which catalyzes the production of another vasoconstrictor, Ang II) (36–38, 43–45).”
BackgroundCritical threshold cerebral hypoperfusion causes Alzheimer's disease?
de la Torre, J. C. (1999) · Acta Neuropathologica · doi:10.1007/s004010051044 · Cited by 124 · cited 1×
“Cerebral hypoperfusion is a risk factor for numerous neurodegenerative diseases including AD (17, 29) DLB (16, 33) Figure 6.”
Background
Cited by
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
Iadecola, C. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.030 · Cited by 2,480
The neuropathology and cerebrovascular mechanisms of dementia
Raz, L., Knoefel, J., & Bhaskar, K. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.164 · Cited by 470
Dementia with Lewy bodies: an update and outlook
Outeiro, T. F., Koss, D. J., Erskine, D., Walker, L., Kurzawa-Akanbi, M., Burn, D., Donaghy, P., Morris, C., Taylor, J.-P., Thomas, A., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0306-8 · Cited by 381
“Reduced cerebral blood flow and microvessel density associated with decreased vascular endothelial growth factor, maybe secondary to α-syn accumulation in the occipital cortex[135], have been suggested.”
BackgroundSkrobot, O. A., Attems, J., Esiri, M., Hortobágyi, T., Ironside, J. W., Kalaria, R. N., King, A., Lammie, G. A., Mann, D., Neal, J., et al. (2016) · Brain · doi:10.1093/brain/aww214 · Cited by 320
Self-citationMiners, J. S., Schulz, I., & Love, S. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17690761 · Cited by 208
“We previously demonstrated that vWF is stable under conditions of simulated post-mortem delay for up to 72 h at 4 C or RT and that vWF level, measured by dot blot, is an excellent indicator of microvessel density.(24,45)”
Self-citation
Metadata
- Authors
- Miners, S., Moulding, H., de Silva, R., & Love, S.
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2014-03-28
- Volume
- 24
- Issue
- 4
- Pages
- 334-343
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- OpenAlex
- W1914043278
- Cited by
- 43
- References
- 12
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reduced Vascular Endothelial Growth Factor and Capillary Density in the Occipital Cortex in Dementia with Lewy Bodies. https://app.cochat.ai/papers/10.1111/bpa.12130
- The paper
- Miners, S., Moulding, H., de Silva, R., & Love, S. (2014). Reduced Vascular Endothelial Growth Factor and Capillary Density in the Occipital Cortex in Dementia with Lewy Bodies. Brain Pathology. https://doi.org/10.1111/bpa.12130
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.